Abstract

We present the case of a 58 year old man who developed pleuritic chest while an in-patient; investigations revealed pulmonary embolism, despite a significantly raised Activated Partial Thromboplastin Time (APTT), which was subsequently attributed to Antiphospholipid syndrome (APS). The diagnosis and initial management of APS in the acute setting is discussed.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Mattai A. Clinical Vignette. Approach to the patient with isolated prolonged APTT: Aetiology, Diagnosis and Management in three cases. Proceedings of UCLA Healthcare. 2011:(15).
2. Provan D, Singer C, Baglin T, et al; Oxford Handbook of Clinical Haematology third edition. New York: Oxford University Press; 2009. p.452, 530-1.
3. Mackworth-Young CG, Loizou S, Walport MJ. Antiphospholipid antibodies and disease. Q J Med. 1989;72(269):767-77.
4. Hanly J. Antiphospholipid syndrome: an overview. CMAJ. 2003;168(13):1675-1683.
5. Miyakis S, Locksin M. D, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 2006;4: 295–306. doi: 10.1111/j.1538-7836.2006.01753.x.
6. Cohen D, Berger SP, Steup-Beekman GM, et al; Diagnosis and management of the antiphospholipid syndrome. BMJ. 2010;340:c2541.
7. Cervera R, Asherson R A, Acevedo M L, et al. Antiphospholipid syndrome associated with infection: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004;63:1212-1217.
8. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019.
9. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I et al. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011;20(2):206-18.
10. Rodeghiero F, Castaman G, Ruggeri M, et al; Thrombosis in subjects with homozygous and heterozygous factor XII deficiency.Thromb Haemost. 1992;67(5):590.
11. Saito H. Contact factors in health and disease. Semin Thromb Hemost. 1987;13(1):36.
12. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore). 1983;62(4):248-55.
13. Jones DW, Gallimore MJ, Harris SL, Winter M. Antibodies to factor XII associated with lupus anticoagulant. Thromb Haemost. 1999;81(3):387-90.
14. Keeling D, Mackie I, Moore GW, Greaves M and the British Committee for standards in Haematology. Guidelines on the Investigation and Management of Antiphospholipid syndrome. BJH 2012;157(1):47-58.